scholarly journals Analysis of nutrition clinical studies involving children in the Middle East and globally

2018 ◽  
Vol 4 (9) ◽  
pp. FSO334
Author(s):  
Fatih Ozdener ◽  
Feza Kirbiyik ◽  
Ali Evrim Dogan
1965 ◽  
Vol 17 (3) ◽  
pp. 148-151
Author(s):  
R. Y. ASFOUR ◽  
R. I. TANNOUS ◽  
Z. I. SABRY ◽  
J. W. COWAN

1952 ◽  
Vol 98 (410) ◽  
pp. 130-142 ◽  
Author(s):  
Denis Leigh

It is now well recognized that many of the syndromes previously described as pellagra, such as nutritional retrobulbar neuropathy, the ataxic, and burning feet syndromes, may occur as isolated manifestations of nutritional deficiency. The term “pellagra,” as it is often used, is no more than a generic title embracing a wide variety of nutritional disorders. The clinical status of the individual deficiency syndromes has been elucidated of late years in America (Spies et al., 1939; Harris, 1941), and with particular regard to the neurological disorders, in groups of prisoners of war in the Far East (Denny Brown, 1947) and Middle East (Spillane, 1947). The majority of the pathological studies of pellagra were completed in the era before advancing biochemical knowledge provided the impetus to further these clinical studies, and this is reflected in the great diversity of neuropathological changes described as “pellagrous.” The extensive literature contains many excellent studies of cases dying from malnutrition, and it now seems possible to attempt a correlation between the pathological findings and the more recently described individual syndromes. A review, therefore, of the neuropathological changes encountered in “pellagra” might be not untimely.


2009 ◽  
Vol 46 (1) ◽  
pp. 85-89 ◽  
Author(s):  
E. Kathryn Miller ◽  
Najwa Khuri-Bulos ◽  
John V. Williams ◽  
Asem A. Shehabi ◽  
Samir Faouri ◽  
...  

Author(s):  
Jie Xu ◽  
Ke Cao ◽  
Lin Zhao ◽  
Zhihui Feng ◽  
Zhizhong Dong ◽  
...  

Metabolic syndrome, such as obesity, diabetes and cardiovascular disease, is becoming epidemic both in developing and developed countries in recent years. Vegetable and fruit consumptions have been associated with the prevention of metabolic syndrome. Pomegranate is a widely consumed fruit in Middle East and Asia. Currently, accumulating data showed that pomegranate exhibits antioxidant, anti-inflammatory, hypolipidemic and hypoglycemic activities in experimental and clinical studies. The beneficial effects of pomegranate may come from its rich polyphenols and be mediated by increasing the activity of AMPK, upregulating GLUT4, activating PPAR[Formula: see text]- ABCA1/CYP7A1 pathways and improving mitochondrial function. This review provides a systematical presentation of findings on the beneficial effects as well as the possible mechanisms of pomegranate and its major components on prevention and treatment of metabolic syndrome.


Sign in / Sign up

Export Citation Format

Share Document